Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 1
2007 1
2008 11
2009 11
2010 8
2011 17
2012 15
2013 10
2014 4
2015 5
2016 3
2017 4
2018 2
2019 1
2020 3
2021 4
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous lupus erythematosus: diagnosis and treatment.
Okon LG, Werth VP. Okon LG, et al. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):391-404. doi: 10.1016/j.berh.2013.07.008. Best Pract Res Clin Rheumatol. 2013. PMID: 24238695 Free PMC article. Review.
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW. Rider LG, et al. Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S118-57. doi: 10.1002/acr.20532. Arthritis Care Res (Hoboken). 2011. PMID: 22588740 Free PMC article. Review. No abstract available.
Pemphigus.
Santoro FA, Stoopler ET, Werth VP. Santoro FA, et al. Dent Clin North Am. 2013 Oct;57(4):597-610. doi: 10.1016/j.cden.2013.06.002. Epub 2013 Aug 12. Dent Clin North Am. 2013. PMID: 24034068 Free PMC article. Review.
Dermatomyositis.
Krathen MS, Fiorentino D, Werth VP. Krathen MS, et al. Curr Dir Autoimmun. 2008;10:313-32. doi: 10.1159/000131751. Curr Dir Autoimmun. 2008. PMID: 18460893 Free PMC article. Review.
Mucous membrane pemphigoid.
Xu HH, Werth VP, Parisi E, Sollecito TP. Xu HH, et al. Dent Clin North Am. 2013 Oct;57(4):611-30. doi: 10.1016/j.cden.2013.07.003. Epub 2013 Aug 15. Dent Clin North Am. 2013. PMID: 24034069 Free PMC article. Review.
Treatment of cutaneous lupus.
Chang AY, Werth VP. Chang AY, et al. Curr Rheumatol Rep. 2011 Aug;13(4):300-7. doi: 10.1007/s11926-011-0180-z. Curr Rheumatol Rep. 2011. PMID: 21503694 Free PMC article. Review.
Severity score indexes for blistering diseases.
Daniel BS, Hertl M, Werth VP, Eming R, Murrell DF. Daniel BS, et al. Clin Dermatol. 2012 Jan-Feb;30(1):108-13. doi: 10.1016/j.clindermatol.2011.03.017. Clin Dermatol. 2012. PMID: 22137234 Free PMC article. Review.
TNF-alpha production in the skin.
Bashir MM, Sharma MR, Werth VP. Bashir MM, et al. Arch Dermatol Res. 2009 Jan;301(1):87-91. doi: 10.1007/s00403-008-0893-7. Epub 2008 Sep 30. Arch Dermatol Res. 2009. PMID: 18825399 Review.
93 results